Healthix Inc.

“Healthix, inc. Uses adp totalsource, a professional employer organization ("peo"). As a professional employer organization, totalsource provides professional employer services to healthix, inc. In the peo relationship totalsource and healthix, inc. Share certain responsibilities and allocate other employer responsibilities between each other. Healthix, inc. Remains an employer of the worksite employees and totalsource is a co-employer of healthix, inc.'s employees. Healthix, inc. Has: direction and control over employees as is necessary to conduct its business, discharge and fiduciary responsibility it may have, or comply with any applicable licensure, regulatory or statutory requirement of healthix, inc. Control over the day to day job duties of employees and over the job sites at which, or from which employees perform services responsibility over the professional and licensed activities of employees including ensuring that employees are supervised by licensed individuals as required by law and for determining whether an applicant or employee meets healthix, inc.'s hiring criteria and is qualified to safely and completely perform his or her job totalsource reserves a right of direction and control over employees as is necessary to fulfill its obligations and provide its services under an agreement between healthix, inc. And totalsource. Totalsource and healthix, inc. Have a right to hire, discipline, and terminate employees as to each one's employment relationship with employees. The peo was paid $130,460 during 2020 for services provided.”

“The organization amended its bylaws during fy2020 to reflect the following changes: (1) added a class of 5 protected members for a 5 year period after the date of the nycig merger. (2) added a requirement that for any individual who serves as a board or committee member, such person must attend at least 70% of board or those committee meetings which are held on an annual basis. If not done, such individual shall be automatically removed as a director and a member. (3) added to the by-laws the requirements for the governance, research & finance committees. (4) removed the nominating committee and the position of executive vp & general counsel”

“Membership: in order for an organization or individual to qualify to be a participant in the regional health information organization ("rhio") operated by the corporation ("participant"), he/she or it must enter into a rhio services, participation or similar agreement with the corporation (each, a "rhio services agreement"), the form of which has been approved by the board of directors of the corporation ("board"), to participate in a clinical information data exchange program with the corporation and to act as a data source and/or data user with respect to the corporation's data exchange. A participant's participation in the corporation will terminate if the rhio services agreement is terminated for any reason.”

“After the form is prepared by outside accountants, it will first be reviewed by the svp & cfo. If there are any suggested changes or modifications, he will communicate directly with the outside accountants. Once the svp & cfo is satisfied with the 990, he will pass it on to the ceo for his review. Once the ceo is satisfied with the 990, the next step is to pass it on to the chairman of the finance committee, who is a member of the executive committee and the board of directors, for his review. Once this individual is satisfied with the 990, it will be passed on to the full executive committee. This committee is a subset of the full healthix, inc. Board and is charged with making many key decisions affecting the company. It is this group of individuals that will authorize the filing of the 990. Once the executive committee is satisfied with the 990 and has authorized its filing, the svp & cfo will provide an electronic copy to the full board of directors prior to the extended due date of the return. The board will be informed that the executive committee has reviewed and approved the 990. If any board member has any questions or concerns they will be instructed to contact the svp & cfo, who will resolve their inquiries promptly.”

“All directors, officers, and key persons will, at least annually thereafter, file a written conflict of interest disclosure statement with healthix senior director of compliance. Healthix senior director of compliance will provide copies of all completed statements to the chair of the audit and compliance committee of the board for review. New director must file conflict of interest prior to being elected to become a healthix board member. For directors, the conflict of interest disclosure statement will specifically include, among other disclosable conflicts of interest, a statement identifying, to the best of the director's knowledge, any entity of which he or she is an officer, director, trustee, member, owner (either as a sole proprietor or a partner), or employee and with which healthix has a relationship, and any transaction in which healthix is a participant and in which the director might have a disclosable conflict of interest. All completed conflict of interest disclosure statements that raise an actual or potential conflict of interest, or that create the appearance of an actual or potential conflict of interest, will be forwarded by the chair of the audit and compliance committee to the audit and compliance committee for their consideration. The audit and compliance committee of the board will conduct a full review of all matters (e.g., contracts, transactions or arrangements) for which an actual or potential conflict of interest or the appearance of an actual or potential conflict of interest has been identified. In so doing, the audit and compliance committee of the board will: a. Consider all relevant facts and circumstances involved in the matter, and in particular, what is fair, reasonable and in the best interests of healthix; b. Exclude the affected individual(s) from being present at or participating in, or being counted in the quorum for, the deliberations or voting on the matter; c. Prohibit the affected individual(s) from any attempt to influence improperly the deliberations or voting on the matter; d. Permit the affected individual(s), upon request of the audit and compliance committee of the board, to present information concerning the matter at a meeting prior to commencement of deliberations or voting on the matter. E. Not permit any director to vote or be counted in determining the quorum for any vote, on any transaction between healthix and another corporation, firm, association or other entity in which the director is an officer or director or has a direct or indirect substantial financial interest. The audit and compliance committee of the board will make a final and binding determination as to whether a conflict of interest exists or may exist on any matter in which there is a disclosable conflict of interest, and what course healthix will take in connection with the matter. The audit and compliance committee of the board will contemporaneously document in writing in appropriate minutes of any meeting at which the matter is deliberated or voted upon all deliberations and determinations relating thereto, including, at a minimum: 1. The names and positions of persons who disclosed that they were related parties or otherwise were found to be related parties or to have a conflict of interest, a description of the nature of the relationship and/or substantial financial interest which gave rise to such disclosure or identification, and a description of the contract, transaction or arrangement at issue; 2. The names of the audit and compliance committee who were present during the taking of the action to determine whether a conflict of interests was present, and the basis for there being a quorum for the taking of such action without including any related parties or affected parties; 3. The steps taken by the audit and compliance committee members of the board to determine whether a conflict of interest was present; 4. The audit and compliance committee board member's decision as to whether a conflict”

“In 2019, the company engaged the services of an independent compensation consulting company, the "jer hr group, llc,", which performed a formal market study and provided ranges for salaries for executives, key employees and for most positions in the company. This consultants' report was finalized in january 2020 & the report provided a variety of data, including the median market salary for most positions. The consultants' conclusions were that salary adjustment should be made for employees whose salary was 15% or more below their market median. In 2020, the company made salary adjustments using 12% as as opposed to 15%, (within a total % cap for a salary increase) as management felt that this a better criteria. Goals were set for all employees at the beginning of 2020, and their performance was measured against goals after 2020 concluded. Bonuses which were accrued at 12/31/19 (based on 2019 performance) were paid in 2020, and those which were accrued at 12/31/20 (based on 2020 performance) were paid out in 2021. The incentive compensation (i.e. Bonus) and merit increase programs were approved by the executive committee for both 2020 & 2019, and were also distributed to all employees. The by-laws create a committee of the board with full powers of the board to review and approve the compensation of officers and other key employees. The committee, which is healthix's executive committee, consists of trustees who have no connection to healthix except as trustees and they have no conflicts as to matters they consider. The committee meets several times a year as needed and always reviews and determines officer and key employee compensation. For purposes of their review the committee considers the recommendations of the ceo for all persons other than the ceo. This process was last undertaken in 2020. The board's approval for the compensation of officers and other key employees is documented via email.”

“The organization makes its form 990 and form 1023 available for public inspection as required under section 6104 of the internal revenue code. It is posted on guidestar.org and other similar types of websites. In addition, the financial statements, conflict of interest policy, articles of incorporation and by-laws are also available upon written request or by calling the organization directly.”

“Objectives of the nysdoh leads system the threat of antimicrobial resistance (ar) continues to grow. The cdc estimates that at least two million people become infected with antibiotic resistant bacteria and at least 23,000 people die each year as a direct result of these infections within the united states. In an effort to address this emerging public health need, new york state department of health laboratory, epidemiology, digital team ("nys-doh") and ilm health solutions, llc ("ilm") worked collaboratively to build a sustainable, flexible infectious diseases reporting, tracking and surveillance tool for ar that can be applied across new york state. The goal of this project was to improve patient outcomes and save health care dollars by integrating real time epidemiologic surveillance with rapid delivery of results to care givers via web-based and mobile platforms. Goal the goal of this project was to assess whether to deploy a rapid state-wide alert system to notify health care facilities of patients with antimicrobial resistant infections as they move from facility to facility and to assess a rapid diagnostic platform to determine a patient's genomic profile and antibiogram to allow targeted infection control and treatment. The project commenced in 2019 as a small-scale demonstration project that included pilots with nyu langone medical center and northwell health. Year 1 ended in march of 2020 and year 2 commenced in april of 2020. In year 2 we added southampton, stony brook, medisys and catholic health services of long island comprising a total of nine additional hospitals. Description for the demonstration project, ilum and healthix established interoperability of patient clinical records. Adt and oru messages were routed to ilum as they are received by healthix in the participant feeds. Healthix has also established an api interface to support the query by idc for healthix patient enterprise id (eid) from the healthix mpi for record linking. During the year ended december 31, 2020, the company recorded $96,000 in revenue in connection with this program. 7. The covid-19 registry project goal the new york state department of health (nys doh) is seeking a system of capabilities that can help the doh surveillance teams and public health researchers build profiles and understand clinical data on covid-19 patients. Project description healthix leverages its service called clinical information updates (ciu) to provide full longitudinal and follow-up update ccda files to the data lake. Healthix uses the daily incremental file of covid19 positive patients to identify records to be included in the patient member table. From this table, covid-19 positive patients are enrolled in the ciu program: covid-19 positive. Longitudinal and update messages are then sent for all enrolled patients in the ciu feed to the data lake. Healthix also uses the full file containing covid19 orders and results to enroll patients in the healthix covid-19 cen program, which alerts all healthix participants of the different covid-19 events. During the year ended december 31, 2020, the company recorded $617,231 in revenue in connection with this program. Effective march 13, 2020, in a transaction in which no cash or stock was exchanged, all of the assets and liabilities of the interboro regional health information organization, inc., d/b/a the new york care information gateway ("nycig") were acquired and assumed by heathix. At this effective date, the identity and separate existence of nycig ceased and healthix remained as the surviving corporation. Similar to healthix, nycig was a tax-exempt new york corporation under section 501(a) of the code and was exempt from federal income taxes pursuant to section 501(c)(3) of the code. Nycig was also exempt from new york state and local income taxes, and its members consisted primarily of certain hospitals and health care providers in new york city and on long island. Nycig was in the same line of business as hea”

“The organization's audit and compliance committee assumes responsibility for the oversight of the audit of its financial statements and selection of its independent auditors. The policy for selection and oversight of the independent auditors has not changed since last year.”